Antibody Drug Conjugates Contract Manufacturing Market: Technology Drives Manufacturing Innovation
The antibody drug conjugates contract manufacturing market is gaining momentum as pharmaceutical and biotechnology companies increasingly rely on specialized manufacturing partners to support complex oncology therapies. Antibody Drug Conjugates Contract Manufacturing Market valued at USD 8.9 billion in 2024, the market is projected to reach USD 16.5 billion by 2030, expanding at a 10.9% CAGR...
0 Commentarii 0 Distribuiri 6 Views 0 previzualizare